Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19088760rdf:typepubmed:Citationlld:pubmed
pubmed-article:19088760lifeskim:mentionsumls-concept:C0596890lld:lifeskim
pubmed-article:19088760lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:19088760lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:19088760lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:19088760lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:19088760pubmed:issue6lld:pubmed
pubmed-article:19088760pubmed:dateCreated2008-12-17lld:pubmed
pubmed-article:19088760pubmed:abstractTextThe chemical synthesis of (22R,23R)-3beta-hydroxy-22,23-epoxy-5alpha-ergost-8(14)-en-15-one from (22E)-3beta-acetoxy-5alpha-ergosta-7,14,22-triene was improved. The stages of obtaining and isomerizing (22E)-3beta-acetoxy-14alpha,15alpha-epoxy-5alpha-ergosta-7,22-diene were optimized. The introduction of the (22R,23R)-epoxide cycle was carried out by a basic treatment of intermediate (22S,23R)-3beta,23-diacetoxy-22-iodo-5alpha-ergost-8(14)-en-15-one. In cells of human mammary gland carcinoma MCF-7 (22R,23R)-3beta-hydroxy-22,23-epoxy-5alpha-ergost-8(14)-en-15-one showed a high toxicity (TC(50) = 0.4 +/- 0.1 microM for 48-h incubation in serum-free medium).lld:pubmed
pubmed-article:19088760pubmed:languageruslld:pubmed
pubmed-article:19088760pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:citationSubsetIMlld:pubmed
pubmed-article:19088760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19088760pubmed:statusMEDLINElld:pubmed
pubmed-article:19088760pubmed:issn0132-3423lld:pubmed
pubmed-article:19088760pubmed:authorpubmed-author:TimofeevV PVPlld:pubmed
pubmed-article:19088760pubmed:authorpubmed-author:MisharinA...lld:pubmed
pubmed-article:19088760pubmed:authorpubmed-author:MekhtievA RARlld:pubmed
pubmed-article:19088760pubmed:issnTypePrintlld:pubmed
pubmed-article:19088760pubmed:volume34lld:pubmed
pubmed-article:19088760pubmed:ownerNLMlld:pubmed
pubmed-article:19088760pubmed:authorsCompleteYlld:pubmed
pubmed-article:19088760pubmed:pagination840-6lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:meshHeadingpubmed-meshheading:19088760...lld:pubmed
pubmed-article:19088760pubmed:articleTitle[(22R,23R)-3beta-Hydroxy-22,23-epoxy-5alpha-ergost-8(14)-en-15-one: improved synthesis and toxicity to MCF-7 cells].lld:pubmed
pubmed-article:19088760pubmed:affiliationOrekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Pogodinskaya ul. 10, Moscow, 119992 Russia.lld:pubmed
pubmed-article:19088760pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19088760pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:19088760pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed